Cargando…
Combination of vildagliptin and rosiglitazone ameliorates nonalcoholic fatty liver disease in C57BL/6 mice
OBJECTIVES: To evaluate the effect of vildagliptin alone and in combination with metformin or rosiglitazone on murine hepatic steatosis in diet-induced nonalcoholic fatty liver disease (NAFLD). MATERIALS AND METHODS: Male C57BL/6 mice were fed with high fat diet (60 Kcal %) and fructose (40%) in dri...
Autores principales: | Mookkan, Jeyamurugan, De, Soumita, Shetty, Pranesha, Kulkarni, Nagaraj M., Devisingh, Vijayaraj, Jaji, Mallikarjun S., Lakshmi, Vinitha P., Chaudhary, Shilpee, Kulathingal, Jayanarayan, Rajesh, Navin B., Narayanan, Shridhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912807/ https://www.ncbi.nlm.nih.gov/pubmed/24550584 http://dx.doi.org/10.4103/0253-7613.125166 |
Ejemplares similares
-
Omega-3 fatty acid-rich fish oil supplementation prevents rosiglitazone-induced osteopenia in aging C57BL/6 mice and in vitro studies
por: Cugno, Chiara, et al.
Publicado: (2021) -
Responses to ethanol in C57BL/6 versus C57BL/6 × 129 hybrid mice
por: Lim, Jana P, et al.
Publicado: (2012) -
Ten Years of Vildagliptin
por: Del Prato, Stefano
Publicado: (2017) -
Surfing the Vildagliptin Tsunami
por: Balachandran, Karthik
Publicado: (2020) -
Similar responsiveness between C57BL/6N and C57BL/6J mouse substrains to superovulation
por: Shindo, Miyuki, et al.
Publicado: (2021)